Study highlights role of cerebellum in Parkinson's learning, memory problems
Written by Marisa Horak, MS | Oct. 8, 2026
- Chemical changes in the cerebellum, particularly involving the neurotransmitter glutamate, are linked to cognitive impairment in Parkinson's disease.
- Patients with cognitive issues showed reduced glutamate signaling markers, especially in the right side of the cerebellum.
- Researchers emphasize the need for larger studies to validate findings and track how these brain changes progress.
Chemical changes in the brain region known as the cerebellum may play a key role in the cognitive issues experienced by people with Parkinson’s disease, a study found. The researchers used specialized MRI scans to track glutamate, a brain signaling molecule, and pinpoint the connection.
The team stressed, however, that the study was limited to a small number of patients, and emphasized the need for further tests to validate their findings. Still, they said, their findings “highlight the potential role of [the] cerebellum in [Parkinson’s]-related cognitive dysfunction.”
The study, “Cerebellar Glutamate Chemical Exchange Saturation Transfer Alterations Correlated With Cognitive Impairment in Parkinson’s Disease,” was published in NMR In Biomedicine.
Cognitive issues, such as difficulty with learning and memory, are common nonmotor symptoms of Parkinson’s. But the specific changes in the brain that lead to cognitive problems in Parkinson’s are not well defined.
Recent Comments